Bavarian Nordic
Edit

Bavarian Nordic

http://www.bavarian-nordic.com/
Last activity: 29.04.2024
Categories: PersonalPlatformProductTechnologyWorkplaceBioTechCommerceDevelopmentITManufacturing
For us, it is all about improving and saving lives Improving and saving lives through innovative vaccines is at the heart of what we do in Bavarian Nordic, and we have more than 25 years of experience in developing life-saving vaccines. We are a fully integrated vaccines company focused on the development, manufacturing and commercialization of our vaccines, and our vision is to become one of the largest pure play vaccine companies in the world. We are a global leader in smallpox and monkeypox vaccines and our commercial product portfolio contains market-leading vaccines against rabies and tick-borne encephalitis as well as an Ebola vaccine, which is developed using our live virus vaccine platform technology, MVA-BN®. Our late-stage pipeline comprises a novel COVID-19 vaccine for boosting existing immunity and a vaccine against respiratory syncytial virus (RSV), for which no approved vaccines exist today. Our values – our Bavarian Nordic DNA, as we like to call it – is what guides our actions. We act as persistent pioneers, we are embracing change, we value being boosted by the team, and we believe in protecting lives every day. If that is also a part of your DNA, we invite you to join us in Bavarian Nordic! We are a global team of more than 900 dedicated people with diverse backgrounds and viewpoints who are bound together by our commitment to protect lives every day. We believe in creating an inclusive and flexible workplace with a strong focus on personal and professional development, because we need each other to take things further. We operate in a world in constant flux and always explore new opportunities. So, if you are open-minded and have the willpower to succeed, we might just be a perfect fit. See your career opportunities at www.bavarian-nordic.com/careers
Followers
2.53K
Followers
36.24K
Website visits
31.9K /mo.
Mentions
38
Location: Denmark, Capital Region of Denmark, Copenhagen
Employees: 501-1000
Total raised: $277.78M
Founded date: 1994

Funding Rounds 3

DateSeriesAmountInvestors
03.08.2023-$120M-
19.05.2016-$101M-
12.05.2015-$56.78M-

Mentions in press and media 38

DateTitleDescriptionSource
29.04.2024Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox...-globenewsw...
13.03.2024Bavarian Nordic Receives Approval of Smallpox and Mpox Vacci...-globenewsw...
12.03.2024Report of transactions of shares and related securities of B...-globenewsw...
06.03.2024Report of transactions of shares and related securities of B...-globenewsw...
06.03.2024Bavarian Nordic Publishes Annual Report 2023-globenewsw...
31.08.2023Phase III secondary endpoint data announced for the COVID-19...Phase III secondary endpoint data announced for the COVID-19 booster vaccine candidate Thu, Aug 31, ...news.cisio...
03.08.2023Bavarian Nordic Receives USD 120 Million Contract for the Ma...-globenewsw...
03.08.2023Bavarian Nordic Receives USD 120 Million Contract for the Ma...German-Danish vaccine manufacturer Bavarian Nordic A/S received a new order valued at USD 120 millio...bio-m.org/...
27.06.2023Phase III topline results announced for the COVID-19 booster...Phase III topline results announced for the COVID-19 booster vaccine candidate Tue, Jun 27, 2023 14:...news.cisio...
16.06.202312-month durability data announced for ABNCoV2 Phase II clin...12-month durability data announced for ABNCoV2 Phase II clinical trial Fri, Jun 16, 2023 09:30 CET R...news.cisio...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In